LONDON (Reuters) - AstraZeneca has signed up Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to identify patients who will benefit from its lung cancer drugs.
via Reuters: Health News Read More Here..
No comments:
Post a Comment